• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    47.65 Down 0.17(0.36%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:47.82
    Open:48.00
    Bid:47.50 x 100
    Ask:N/A
    1y Target Est:45.38
    Beta:2.83
    Next Earnings Date:30-Jul-15SGEN Earnings announcement
    Day's Range:47.40 - 48.67
    52wk Range:30.05 - 49.84
    Volume:788,278
    Avg Vol (3m):995,167
    Market Cap:5.95B
    P/E (ttm):N/A
    EPS (ttm):-0.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENDown 0.36%5.95B
    IMGNDown 1.82%1.21B
    PFEDown 0.95%205.48B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.86
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.84
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-3.27

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback